CAJ | 학술논문

目的：通过临床观察有无梗死前心绞痛对急性心肌梗死的影响，分析梗死前心绞痛在急性心肌梗死患者行急性溶栓及经皮冠状动脉腔内血管成形术（PTCA）中的保护作用。方法回顾性分析94例急性心肌梗死患者的临床资料，根据治疗方式分为A、B两组，A组患者行急性溶栓治疗，B组患者行PTCA治疗，观察两组患者梗死前有无心绞痛对其预后的影响。结果 A组中，梗死前有无心绞痛患者在血管开通率、心肌酶峰值、心力衰竭、心源性休克、死亡率方面比较差异具有显著性（P＜0.05）。B组中，梗死前有无心绞痛患者在血管开通率、心肌酶峰值、心力衰竭、心源性休克、死亡率方面，存在差异但无显著性（P＞0.05）。结论梗死前心绞痛在急性心肌梗死患者行急性溶栓中保护作用较为明显，在急性PTCA中的保护作用由于支架的置入而被掩盖；但急性PTCA治疗较溶栓治疗可显著降低死亡率，减少并发症的发生，缩短患者住院时间。
목적：통과림상관찰유무경사전심교통대급성심기경사적영향，분석경사전심교통재급성심기경사환자행급성용전급경피관상동맥강내혈관성형술（PTCA）중적보호작용。방법회고성분석94례급성심기경사환자적림상자료，근거치료방식분위A、B량조，A조환자행급성용전치료，B조환자행PTCA치료，관찰량조환자경사전유무심교통대기예후적영향。결과 A조중，경사전유무심교통환자재혈관개통솔、심기매봉치、심력쇠갈、심원성휴극、사망솔방면비교차이구유현저성（P＜0.05）。B조중，경사전유무심교통환자재혈관개통솔、심기매봉치、심력쇠갈、심원성휴극、사망솔방면，존재차이단무현저성（P＞0.05）。결론경사전심교통재급성심기경사환자행급성용전중보호작용교위명현，재급성PTCA중적보호작용유우지가적치입이피엄개；단급성PTCA치료교용전치료가현저강저사망솔，감소병발증적발생，축단환자주원시간。
Objective Through clinical observation is not affect the stem acute myocardial infarction, angina pectoris before analysis. In patients with acute myocardial infarction thrombolysis and percutaneous transluminal coronary angioplasty (PTCA) in the protective effects of. Method 94 cases of patients with acute myocardial infarction patients were selected, according to the selected patients were divided into two groups, group A underwent emergency thrombolytic therapy, group B treated with PTCA, effect of angina pectoris on the prognosis of the patients were compared between two groups before ami. Result In group A, patients with stem angina pectoris before opening rate, peak value of myocardial enzyme, heart failure, cardiogenic shock and death rate in blood vessels, the difference was statistically signiifcant (P<0.05). In group B, myocardial infarction, angina pectoris patients before the patency rate, peak value of myocardial enzyme, heart failure, cardiogenic shock, mortality, there were differences but no statistical signiifcance (P > 0.05). Conclusion Myocardial infarction angina in patients with acute myocardial infarction thrombolysis in protective effect more obvious, protection in acute PTCA may be concealed by stenting;and emergency PTCA treatment emergent thrombolytic therapy can signiifcantly reduce the mortality rate, reduce infarct complications, shorten the days in hospital.